share_log

Enanta Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

SEC ·  Nov 23, 2023 05:38
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.